Document Detail

Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
MedLine Citation:
PMID:  22909369     Owner:  NLM     Status:  In-Data-Review    
Vitiligo is an acquired depigmenting disorder having disfiguring consequences. Many treatments have been attempted with varying reports of success. A parallel-group, assessor blinded, randomized, controlled trial was designed to compare the efficacy and adverse effects of narrowband UVB (NBUVB) with oral psoralen UVA (PUVA) therapy in the treatment of vitiligo. Patients aged 13-70 years with vitiliginous lesions involving more than 5% body surface area were eligible for the study. In total, 56 patients were randomized in a 1 : 1 ratio to oral PUVA or NBUVB phototherapy groups. Patients were assessed for the percentage of repigmentation over the depigmented areas as the primary outcome measure at each visit during the first three months and then monthly within the next three months. The incidence of adverse effects was also noted during the study period as the secondary outcome measure. The median repigmentation achieved at the end of the six-month therapy course was 45% in the NBUVB group and 40% in the oral PUVA group. Focal vitiligo had the best response in both treatment groups. There were lesser adverse effects within the NBUVB (7.4%) than in the PUVA (57.2%) group. Two PUVA patients discontinued therapy due to severe dizziness. There was no significant difference in the mean degree of repigmentation; however, NBUVB carried a greater response rate and might be superior to oral PUVA with better tolerance and color match with the surrounding normal skin, as well as fewer side effects in the treatment of vitiligo.
Ranjeeta Sapam; Sudha Agrawal; Tapan K Dhali
Related Documents :
22285969 - Does additional linear ablation after circumferential pulmonary vein isolation improve ...
16971719 - Oral fingolimod (fty720) for relapsing multiple sclerosis.
8996139 - Phase ii trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defini...
22705939 - Mindful movement program for older breast cancer survivors: a pilot study.
22741049 - A predictive factor in overactive bladder symptoms improvement after combined anterior ...
22780449 - Safety in the use of dexmedetomidine (precedex) for deep brain stimulation surgery: our...
9893539 - The respiratory effects of tramadol in children under halothane an anaesthesia.
22551129 - Registry of transcatheter aortic-valve implantation in high-risk patients.
23030519 - Endovenous laser ablation of incompetent perforating veins with 1470 nm, 400 μm radial...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of dermatology     Volume:  51     ISSN:  1365-4632     ISO Abbreviation:  Int. J. Dermatol.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-08-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243704     Medline TA:  Int J Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1107-15     Citation Subset:  IM    
Copyright Information:
© 2012 The International Society of Dermatology.
From the Department of Dermatology & Venereology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Blastomycosis: a case report and review of the literature.
Next Document:  High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.